Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Bioplan and Arcade Marketing to Form New Venture - Beauty Packaging

What are you searching for?

Sign in
Beauty Industry, Beauty Launches, Mergers and Acquisitions

Bioplan and Arcade Marketing to Form New Venture

The resulting combination would supply sampling solutions for the beauty, fragrance and personal care segments.

Author Image

By: Jamie Matusow

Editor-in-Chief

Ileos, owned by funds managed by Oaktree Capital Management, L.P., and Visant Corporation, controlled by affiliates of KKR and DLJ Merchant Banking, have announced plans to combine their subsidiaries, Bioplan and Arcade Marketing, resulting in the formation of a new strategic venture, under which Oaktree would retain a 75% ownership interest and KKR/DLJMBP would retain a 25% ownership interest.

The proposed combination is based on the complementary aspects of these two businesses in providing sampling solutions for the beauty, fragrance and personal care segments. The new venture’s global sales and manufacturing platform aims to service its customers with an enhanced products and services portfolio.

Ileos (owned by Oaktree since 2011) says it is pursuing its external growth strategy, looking for product and geographic complements to its businesses.

According to Ileos, the proposed combination with Arcade Marketing will allow its subsidiary, Bioplan, to enrich its product portfolio with patented solutions notably using micro encapsulation and other proprietary flat sample technologies.

Arcade Marketing, with similar strategic ambitions, says it looks forward to completing the proposed combination, which will also complement its offerings by benefiting from Bioplan’s production capabilities, including vials and sachets.

With the objective to enhance service to its customers, the combined entity will be able to provide product and service offerings globally relying on a pooling of research, development and manufacturing capabilities fostering continued innovation in sampling solutions.

The new venture is expected to generate turnover of approximately $450 million on a combined basis.

The parties anticipate entering into a definitive transaction agreement once the works’ council consultation process in France is completed. The transaction will be subject to normal and customary closing conditions and regulatory review and is expected to close by the beginning of the fourth quarter of 2014.

Add us as a preferred source on Google

Get the latest Beauty Packaging news, insights and analysis in your Google Search and AI experiences.

Add Beauty Packaging as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Beauty Packaging Newsletters

Topics